CompoAtlas

Amyron Forte sīrups (2023.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0001303/2022
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
SIA "Ramaijana"
Manufacturer
Aimil pharmaceuticals India LTD
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
6 tējkarotes - 30 ml
Published pack size
200 ml
Published packaging
200 ml

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Papaijaplants ; Papaija ; Carica papaya ; ekstrakts ; 240 ; mgcarica papayaPlant
Ašvagandaplants ; Ašvaganda ; Withania somnifera ; ekstrakts ; 150 ; mgwithania somniferaPlant
Puerārijaplants ; Puerārija ; Pueraria tuberosa ; ekstrakts ; 264 ; mgpueraria tuberosaPlant
Sparģelisplants ; Sparģelis ; Asparagus racemosus ; ekstrakts ; 540 ; mgasparagus racemosusPlant
Grieķu trigonellaplants ; Grieķu trigonella ; Trigonella foenum- graecum ; ekstrakts ; 90 ; mgNot recognisedRole not identified
Kumīnsplants ; Kumīns ; Cuminum cyminum ; ekstrakts ; 135 ; mgcuminum cyminumPlant
Mīkstie kviešiplants ; Mīkstie kvieši ; Triticum sativum ; ekstrakts ; 90 ; mgNot recognisedRole not identified
Spinātiplants ; Spināti ; Spinacia oleracea ; ekstrakts ; 60 ; mgspinacia oleraceaPlant
Sojaplants ; Soja ; Glycine max ; ekstrakts ; 60 ; mgglycine maxPlant
Īstais vīnkoksplants ; Īstais vīnkoks ; Vitis vinifera ; ekstrakts ; 420 ; mgvitis viniferaPlant
Amla jeb emblikaplants ; Amla jeb emblika ; Emblica officinalis ; ekstrakts ; 300 ; mgNot recognisedRole not identified
Melnais mirobalānsplants ; Melnais mirobalāns ; Terminalia chebula ; ekstrakts ; 360 ; mgterminalia chebulaPlant
Saulepuķeplants ; Saulepuķe ; Helianthus annuus ; ekstrakts ; 45 ; mghelianthus annuusPlant
Moringaplants ; Moringa ; Moringa oleifera ; ekstrakts ; 66 ; mgmoringa oleiferaPlant
Lakricaplants ; Lakrica ; Glycyrrhiza glabra ; ekstrakts ; 60 ; mgglycyrrhiza glabraPlant
Dateļpalmaplants ; Dateļpalma ; Phoenix dactylifera ; ekstrakts ; 222 ; mgphoenix dactyliferaPlant
Parastais fenhelisplants ; Parastais fenhelis ; Foeniculum vulgare ; ekstrakts ; 3 ; mgfoeniculum vulgarePlant
Tomātsplants ; Tomāts ; Lycopersicon esculentum ; ekstrakts ; 30 ; mglycopersicon esculentumPlant
Ingversplants ; Ingvers ; Zingiber officinalis ; ekstrakts ; 15 ; mgNot recognisedRole not identified
Garais piparsplants ; Garais pipars ; Piper longum ; ekstrakts ; 10,5 ; mgpiper longumPlant
Melnais piparsplants ; Melnais pipars ; Piper nigrum ; ekstrakts ; 9 ; mgpiper nigrumPlant
Indijas ķimeneplants ; Indijas ķimene ; Trachyspermum ammi ; ekstrakts ; 19,5 ; mgtrachyspermum ammiPlant
Kanēļkoksplants ; Kanēļkoks ; Cinnamomum zeylanicum ; ekstrakts ; 4,5 ; mgNot recognisedRole not identified
Parastā bieteplants ; Parastā biete ; Beta vulgaris ; sula ; 1,5 ; mlbeta vulgarisPlant
Granātābolsplants ; Granātābols ; Punica granatum ; sula ; 0,9 ; mlpunica granatumPlant
Ananāssplants ; Ananāss ; Ananas comosus ; sula ; 0,9 ; mlananas comosusPlant
Burkānsplants ; Burkāns ; Daucus carota ; sula ; 0,9 ; mlBêta-carotèneVitamin or mineral
Mīkstie kviešiplants ; Mīkstie kvieši ; Triticum sativum ; eļļa ; 12 ; mgNot recognisedRole not identified
Mīkstie kviešiplants ; Mīkstie kvieši ; Triticum sativum ; sula ; 0,9 ; mlNot recognisedRole not identified
Sējas melnsēklīteplants ; Sējas melnsēklīte ; Nigella sativa ; eļļa ; 12 ; mgnigella sativaPlant
Sējas liniplants ; Sējas lini ; Linum usitatissimum ; eļļa ; 6 ; mglinum usitatissimumPlant
Lēcasplants ; Lēcas ; Lens culinaris ; ekstrakts ; 75 ; mglens culinarisPlant
Ananāsu aromatizētājsotherIngredients ; Ananāsu aromatizētājs ; - ; mgNot recognisedRole not identified
CukursotherIngredients ; Cukurs ; - ; mgNot recognisedRole not identified
130foodAdditives ; 130Not recognisedRole not identified
172foodAdditives ; 172Not recognisedRole not identified
43foodAdditives ; 43Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Indija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ašvaganda
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Soja
    Read the warning, when it applies and the studies cited
  • Lakrica
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Parastais fenhelis
    Read the warning, when it applies and the studies cited

    BITTER FENNEL- FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil and Tincture.

    Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

    SWEET FENNEL -FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Granātābols
    Read the warning, when it applies and the studies cited
  • Burkāns
    Read the warning, when it applies and the studies cited

    CARROT - DAUCUS CAROTA SUBSP. SATIVUS

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 6,000 μg of beta-carotene, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Sējas lini
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line